MENU
KRRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Korro Bio (KRRO) Ownership - Who owns Korro Bio?
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases... Show more
Profile
Industry
N/A
Address
One Kendall Square
Phone
+1 617 468-1999
Employees
102
Web
https://www.korrobio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
162.8M
P/E Ratio
N/A
Total Cash
137M
Projected Growth
N/A
Total Debt
41.79M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
14.59
Total Debt/Equity
N/A
Revenue/Share
0.25 USD as % of share price
Fundamentals
KRRO
Capitalization
163M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
137M
Total Cash/Share
14.59
Total Debt
41.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.25%
Revenue
0
ROE
N/A
Book Value
180M
P/B Ratio
1.01
Cash Flow
N/A
Earnings
-9.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
11.23
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-92.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.05
Shares Held By Institutions
387M
Shares Outstanding - Current
9.39M
Total Liabilities
63.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-58.103
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Kendall Square
Phone
+1 617 468-1999
Employees
102
Web
https://www.korrobio.com